{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-130593","form_type":"8-K","ticker":"LITS","cik":"0001262104","company_name":"Lite Strategy, Inc.","filed_at":"2024-11-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:07.924832+00:00","generated_at":"2026-05-29T18:40:43.651299+00:00","sec_items":["5.08"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"MEI Pharma sets 2025 annual meeting for Jan 30, 2025; record date Dec 9, 2024","bullets":["2025 Annual Meeting to be held on January 30, 2025.","Stockholders of record as of December 9, 2024 entitled to vote.","Deadline for Rule 14a-8 shareholder proposals is December 10, 2024.","Deadline for director nominations outside Rule 14a-8 (Sept 18, 2024) has passed."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-130593","json":"https://secwatch.observer/filing/0000950170-24-130593.json","markdown":"https://secwatch.observer/filing/0000950170-24-130593.md","text":"https://secwatch.observer/filing/0000950170-24-130593.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1262104/000095017024130593/0000950170-24-130593-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1262104/000095017024130593/meip-20241122.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T18:40:43.651299+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}